Dr Suzanne Gazda is a brilliant colleague and integrative neurologist in Texas. There are many ways to diagnose Alzheimer’s, as you know, but the most definitive diagnosis as a post-mortem assessment of the brain. PET scans and other neuroimaging can be quite valuable but often very expensive and tests like PET scans are often not covered by insurance. Dr. Gazda has some good ideas in this article for early diagnosis using some new laboratory tests as well. I really value neuropsychological testing as well so that people can actually get a true window into their own cognition, their strengths and weaknesses in different cognitive areas and a sense of the pattern of their own thinking.
In addition to being a diagnostic tool, Neuropsychological testing can specify the type of cognitive training patients can benefit from. It’s easier to make a prescription for cognitive training once you have solid neuropsychological data and it’s important as part of the diagnostic process. If people have Mild Cognitive Impairment or even Subjective Cognitive Impairment, the neuropsychological test results provide a very good baseline to compare with subsequent testing. The tools Dr. Gazda shares will prove to be very helpful for early diagnosis of Alzheimer’s and maybe even other neurodegenerative illnesses.
Please enjoy Dr Gazda’s latest blog on the how to make an early diagnosis of Alzheimer's Disease with revolutionary biomarkers. https://www.suzannegazdamd.com/blog---long-covid/biomarkers-for-alzheimers-disease-a-revolutionary-tool
Comentários